Nitroglycerin for Management of Retained Placenta: A Multicenter Study
Table 1
Demographic and baseline characteristics (intention to treat group, ITT).
Variable
Nitroglycerin()
Placebo ()
value
Age (years)
0.98
Mean (SD)
31.7 (5.0)
31.7 (5.6)
Median (range)
32 (19; 42)
32 (20; 44)
Parity n (%)
0.77
1
23 (41.8)
24 (42.9)
2
20 (36.4)
22 (39.3)
3
10 (18.2)
7 (12.5)
4
0 (0.0)
2 (3.6)
5
2 (3.6)
1 (1.8)
Site
1.00
A
11 (20.0)
11 (19.6)
B
13 (23.6)
14 (25.0)
C
7 (12.7)
8 (14.3)
D
17 (30.9)
17 (30.4)
E
7 (12.7)
6 (10.7)
Blood loss before treatment (mL)*
0.94
Mean (SD)
554 (464)
548 (457)
Median (range)
450 (50; 2400)
450 (0; 2000)
Time from delivery to administration of nitroglycerin or placebo tablets (minutes)*
0.06
Mean (SD)
49.5 (8.9)
46.3 (7.5)
Median (range)
50 (27; 70)
46 (31; 62)
Intention to treat group, ITT: all randomized patients, including 4 patients who did not receive study medication and 2 patients who only received 0.5 mg nitroglycerin. *Four patients who did not receive study medication are not included.
